市場調查報告書
商品編碼
1298703
皮下注射針頭市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Hypodermic Needles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球皮下注射針頭市場規模達到27億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到41億美元,在2023-2028年期間呈現6.9%的成長率(CAGR)。
皮下注射針是指與注射器一起使用的薄而空的針頭,用於向體內注射物質。它們還協助從體內提取液體,如在靜脈穿刺中從靜脈中提取血樣。它們通常使用不銹鋼管通過拔管工藝製造。皮下注射針還可用於提供不能口服的藥物,因為這些藥物不容易被吸收(如胰島素)或可能傷害病人的肝臟。此外,它們有一個極其光滑和鋒利的表面,在接種無菌基質時可以防止和減少污染。因此,皮下注射針在需要無菌條件的醫療部門和研究環境中得到了廣泛的應用。
皮下注射針被醫務人員、醫生、牙醫和護理人員廣泛用於緊急情況下的快速皮內輸液、疫苗接種、藥物管理和血樣採集,這是推動市場成長的主要因素。此外,感染和慢性病的廣泛流行,如癌症、糖尿病和心血管疾病,使疫苗和注射藥物的需求升級。與此同時,為遏制冠狀病毒病(COVID-19)在全球範圍內的傳播而正在進行的疫苗接種活動,也催化了對皮下注射針頭的需求。除此之外,各國政府實施嚴格的法規,規定使用安全針頭,以防止針頭重複使用,減少感染的風險,這也推動了市場的成長。此外,一些領先的製造商正在開發精密工程的皮下注射針頭,以提高病人在腸外治療中的舒適度,並減少穿刺阻力。他們還在檢查和測試過程中對自動化系統進行大量投資,以滿足品質標準並確保安全用藥。其他因素,包括防止針刺傷害的需求不斷成長,血液傳播疾病病例激增,捐血量增加,醫療保健基礎設施改善,以及技術進步,也在創造一個有利的市場前景。
The global hypodermic needles market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.
Hypodermic needles refer to thin, hollow needles used with a syringe to inject substances into the body. They also assist in extracting fluids from the body, such as taking a blood sample from a vein in venipuncture. They are typically manufactured using stainless-steel tubes through the tube drawing process. Hypodermic needles can also be utilized to provide medications that cannot be ingested orally because they cannot be absorbed easily (like insulin) or potentially harm the patient's liver. Moreover, they have an extremely smooth and sharp surface which prevents and minimizes contamination during inoculation of a sterile substrate. As a result, hypodermic needles find extensive applications in the healthcare sector and research environments requiring sterile conditions.
Hypodermic needles are widely used by medical professionals, physicians, dentists, and paramedics for rapid intradermal delivery of liquids in case of emergencies, vaccination, administration of drugs, and blood sample collection, which represents the primary factor driving the market growth. Additionally, the widespread prevalence of infections and chronic diseases, such as cancer, diabetes, and cardiovascular disorders, has escalated the demand for vaccines and injectable drugs. Along with this, the ongoing vaccination campaigns to curb the spread of coronavirus disease (COVID-19) across the globe are catalyzing the demand for hypodermic needles. Besides this, the implementation of stringent regulations by governments of various countries that mandate the use of safety needles to prevent needle re-usage and mitigate the risk of infections is propelling the market growth. Furthermore, several leading manufacturers are developing precision-engineered hypodermic needles to enhance patient comfort in parenteral therapies and reduce penetration resistance. They are also making heavy investments in automated systems for inspection and testing processes to meet the quality standards and ensure the safe administration of medications. Other factors, including the growing need to prevent needle-stick injuries, surging cases of blood-borne diseases, increasing blood donations, improving healthcare infrastructure, and technological advancements, are also creating a favorable market outlook.
IMARC Group provides an analysis of the key trends in each sub-segment of the global hypodermic needles market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application and end user.
Safety Hypodermic Needles
Non-Safety Hypodermic Needles
Drug Delivery
Vaccination
Blood Specimen Collection
Hospitals and Clinics
Ambulatory Surgical Centers
Diabetic Patients
Family Practices
Psychiatrics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.) and Terumo Corporation.